S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
Log in

NASDAQ:BTAIBioXcel Therapeutics News Headlines

$21.31
+1.64 (+8.34 %)
(As of 04/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$19.18
Now: $21.31
$22.15
50-Day Range
$14.79
MA: $26.32
$41.14
52-Week Range
$3.76
Now: $21.31
$43.63
Volume398,618 shs
Average Volume654,416 shs
Market Capitalization$430.08 million
P/E RatioN/A
Dividend YieldN/A
Beta1.53

Headlines

BioXcel Therapeutics (NASDAQ BTAI) News Headlines

Source:
DateHeadline
BioXcel Therapeutics (NASDAQ:BTAI) Now Covered by Analysts at Bank of AmericaBioXcel Therapeutics (NASDAQ:BTAI) Now Covered by Analysts at Bank of America
www.americanbankingnews.com - April 1 at 4:32 PM
Short Interest in BioXcel Therapeutics Inc (NASDAQ:BTAI) Rises By 57.6%Short Interest in BioXcel Therapeutics Inc (NASDAQ:BTAI) Rises By 57.6%
www.americanbankingnews.com - March 27 at 6:10 PM
Q1 2020 Earnings Estimate for BioXcel Therapeutics Inc (NASDAQ:BTAI) Issued By Zacks Investment ResearchQ1 2020 Earnings Estimate for BioXcel Therapeutics Inc (NASDAQ:BTAI) Issued By Zacks Investment Research
www.americanbankingnews.com - March 20 at 8:35 AM
BioXcel Therapeutics (BTAI) Buy Rating Reiterated at HC WainwrightBioXcel Therapeutics' (BTAI) Buy Rating Reiterated at HC Wainwright
www.americanbankingnews.com - March 20 at 6:40 AM
Zacks: Analysts Expect BioXcel Therapeutics Inc (NASDAQ:BTAI) to Announce -$0.64 EPSZacks: Analysts Expect BioXcel Therapeutics Inc (NASDAQ:BTAI) to Announce -$0.64 EPS
www.americanbankingnews.com - March 19 at 12:24 PM
BioXcel on track to complete BXCL501 studies on timeBioXcel on track to complete BXCL501 studies on time
seekingalpha.com - March 19 at 8:54 AM
BTAI: On Track for Multiple Data Readouts in 2020…BTAI: On Track for Multiple Data Readouts in 2020…
finance.yahoo.com - March 17 at 7:12 PM
BioXcel Therapeutics Inc (NASDAQ:BTAI) Given Average Recommendation of "Buy" by BrokeragesBioXcel Therapeutics Inc (NASDAQ:BTAI) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 16 at 3:34 AM
1 Biotech Stock Defying the Coronavirus Stock Market Sell-Off1 Biotech Stock Defying the Coronavirus Stock Market Sell-Off
www.fool.com - March 15 at 1:07 PM
BioXcel Therapeutics Inc (NASDAQ:BTAI) Short Interest UpdateBioXcel Therapeutics Inc (NASDAQ:BTAI) Short Interest Update
www.americanbankingnews.com - March 14 at 3:16 AM
BioXcel Therapeutics (BTAI) Presents At Barclays Global Healthcare Conference - SlideshowBioXcel Therapeutics (BTAI) Presents At Barclays Global Healthcare Conference - Slideshow
seekingalpha.com - March 10 at 10:44 PM
BioXcel Therapeutics EPS beats by $0.20BioXcel Therapeutics EPS beats by $0.20
seekingalpha.com - March 9 at 9:17 AM
BioXcel Therapeutics, Inc. to Host Earnings CallBioXcel Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - March 9 at 9:17 AM
BioXcel Therapeutics to Host Fourth Quarter and Full Year 2019 Operating and Financial Results Conference Call and WebcastBioXcel Therapeutics to Host Fourth Quarter and Full Year 2019 Operating and Financial Results Conference Call and Webcast
finance.yahoo.com - March 2 at 9:17 AM
BTAI: Financing Strengthens Balance Sheet; Raising Valuation to $92/Share…BTAI: Financing Strengthens Balance Sheet; Raising Valuation to $92/Share…
finance.yahoo.com - February 28 at 7:38 PM
BioXcel Therapeutics to Present at Two Upcoming Healthcare Investor ConferencesBioXcel Therapeutics to Present at Two Upcoming Healthcare Investor Conferences
finance.yahoo.com - February 26 at 8:50 AM
BioXcel down 18% premarket after pricing equity offeringBioXcel down 18% premarket after pricing equity offering
seekingalpha.com - February 20 at 2:10 PM
Why BioXcel Therapeutics Stock Is Swooning TodayWhy BioXcel Therapeutics Stock Is Swooning Today
www.fool.com - February 20 at 2:10 PM
BioXcel announces new mid-stage study of BXCL501; shares up 3% premarketBioXcel announces new mid-stage study of BXCL501; shares up 3% premarket
seekingalpha.com - February 18 at 8:37 AM
BioXcel Therapeutics Announces Initiation of a Phase 2 Study Designed to Assess Agitation-Associated Biomarkers and their Response to BXCL501BioXcel Therapeutics Announces Initiation of a Phase 2 Study Designed to Assess Agitation-Associated Biomarkers and their Response to BXCL501
finance.yahoo.com - February 18 at 8:37 AM
BioXcel Therapeutics (BTAI) Journey From $7 To $41 In Less Than A YearBioXcel Therapeutics' (BTAI) Journey From $7 To $41 In Less Than A Year
www.nasdaq.com - February 14 at 6:04 PM
BioXcel up 76% premarket as SunTrust beats drum on potential upsideBioXcel up 76% premarket as SunTrust beats drum on potential upside
seekingalpha.com - February 14 at 1:03 PM
BioXcel Therapeutics to Present at the 2020 BIO CEO & Investor ConferenceBioXcel Therapeutics to Present at the 2020 BIO CEO & Investor Conference
finance.yahoo.com - February 7 at 8:34 AM
FDA signs off on BioXcel IND for study of BXCL501 for opioid withdrawalFDA signs off on BioXcel IND for study of BXCL501 for opioid withdrawal
seekingalpha.com - February 5 at 8:43 AM
BioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501 for the Treatment of Opioid Withdrawal SymptomsBioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501 for the Treatment of Opioid Withdrawal Symptoms
finance.yahoo.com - February 5 at 8:43 AM
Were Keeping An Eye On BioXcel Therapeuticss (NASDAQ:BTAI) Cash Burn RateWe're Keeping An Eye On BioXcel Therapeutics's (NASDAQ:BTAI) Cash Burn Rate
finance.yahoo.com - January 25 at 11:52 PM
We're Keeping An Eye On BioXcel Therapeutics's (NASDAQ:BTAI) Cash Burn RateWe're Keeping An Eye On BioXcel Therapeutics's (NASDAQ:BTAI) Cash Burn Rate
finance.yahoo.com - January 25 at 1:51 PM
BioXcel Therapeutics: AI-Focused Biopharmaceutical Player For 2020BioXcel Therapeutics: AI-Focused Biopharmaceutical Player For 2020
seekingalpha.com - January 23 at 4:39 PM
PTLA, NKTR, SRNE and SIX among midday moversPTLA, NKTR, SRNE and SIX among midday movers
seekingalpha.com - January 10 at 3:19 PM
BTAI: Potentially Transformative Year Ahead for BioXcel…BTAI: Potentially Transformative Year Ahead for BioXcel…
finance.yahoo.com - January 10 at 3:19 PM
BioXcel Therapeutics (BTAI) Ends The Year On High Note, Stock Up Over 300% BioXcel Therapeutics (BTAI) Ends The Year On High Note, Stock Up Over 300%
www.rttnews.com - December 31 at 11:48 PM
BioXcel Therapeutics Announces Initiation of...BioXcel Therapeutics Announces Initiation of...
www.benzinga.com - December 30 at 10:54 AM
Topline results expected in mid-2020Topline results expected in mid-2020
www.globenewswire.com - December 30 at 10:54 AM
BioXcel commences late-stage studies of BXCL501; shares up 9% premarketBioXcel commences late-stage studies of BXCL501; shares up 9% premarket
seekingalpha.com - December 30 at 10:54 AM
BioXcel Therapeutics Announces Initiation of Pivotal Phase 3 Studies of BXCL501 for Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar DisorderBioXcel Therapeutics Announces Initiation of Pivotal Phase 3 Studies of BXCL501 for Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder
finance.yahoo.com - December 30 at 10:54 AM
Hedge Funds Have Never Been This Bullish On BioXcel Therapeutics, Inc. (BTAI)Hedge Funds Have Never Been This Bullish On BioXcel Therapeutics, Inc. (BTAI)
finance.yahoo.com - December 22 at 11:03 PM
BioXcel Therapeutics to Expand Study of BXCL701 into Multiple Advanced Solid Tumor TypesBioXcel Therapeutics to Expand Study of BXCL701 into Multiple Advanced Solid Tumor Types
finance.yahoo.com - December 11 at 7:53 AM
BTAI: Pivotal Phase 3 Trials for BXCL501 to Initiate by End of 2019…BTAI: Pivotal Phase 3 Trials for BXCL501 to Initiate by End of 2019…
finance.yahoo.com - December 6 at 1:47 PM
BioXcel up 5% on advancement of BXCL501BioXcel up 5% on advancement of BXCL501
seekingalpha.com - December 3 at 12:24 PM
BioXcel Therapeutics Prepares to Initiate Pivotal Phase 3 Studies with BXCL501 Following Positive End-of-Phase 2 Meeting with FDABioXcel Therapeutics Prepares to Initiate Pivotal Phase 3 Studies with BXCL501 Following Positive End-of-Phase 2 Meeting with FDA
finance.yahoo.com - December 3 at 7:24 AM
BioXcel Therapeutics to Present at the Piper Jaffray 31st Annual Healthcare ConferenceBioXcel Therapeutics to Present at the Piper Jaffray 31st Annual Healthcare Conference
finance.yahoo.com - November 26 at 8:39 AM
BTAI: Phase 3 Trials of BXCL501 in Agitation to Initiate Before Year End…BTAI: Phase 3 Trials of BXCL501 in Agitation to Initiate Before Year End…
finance.yahoo.com - November 21 at 12:58 PM
BioXcel Therapeutics, Inc. (BTAI) CEO Vimal Mehta on Q3 2019 Results - Earnings Call TranscriptBioXcel Therapeutics, Inc. (BTAI) CEO Vimal Mehta on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 5:21 PM
BioXcel Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business UpdateBioXcel Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 14 at 7:19 AM
BioXcel Therapeutics to Host Third Quarter 2019 Operating and Financial Results Conference Call and WebcastBioXcel Therapeutics to Host Third Quarter 2019 Operating and Financial Results Conference Call and Webcast
finance.yahoo.com - November 7 at 7:32 AM
BTAI: Initiating Coverage of BioXcel Therapeutics, Inc.; AI Driven Drug DevelopmentBTAI: Initiating Coverage of BioXcel Therapeutics, Inc.; AI Driven Drug Development
finance.yahoo.com - October 30 at 1:34 PM
How Many BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Shares Did Insiders Buy, In The Last Year?How Many BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Shares Did Insiders Buy, In The Last Year?
finance.yahoo.com - October 27 at 1:04 PM
BioXcel Therapeutics to Present at the 26th Annual Prostate Cancer Foundation Scientific RetreatBioXcel Therapeutics to Present at the 26th Annual Prostate Cancer Foundation Scientific Retreat
finance.yahoo.com - October 24 at 8:55 AM
BioXcel Therapeutics Highlights Upcoming Major MilestonesBioXcel Therapeutics Highlights Upcoming Major Milestones
finance.yahoo.com - October 10 at 12:34 PM
BioXcel Therapeutics Announces Pricing of Public Offering of Common StockBioXcel Therapeutics Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - September 26 at 4:58 PM
This page was last updated on 4/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel